ADD-ON TRIAL IN THERAPY-RESISTANT PATIENTS - AN APPROPRIATE METHOD FOR EVALUATING NEW ANTIEPILEPTIC DRUGS

被引：0
|
作者：
BULAU, P [1 ]
机构：
[1] UNIV BONN, NERVENKLIN EPILEPTOL, D-5300 BONN, GERMANY
来源：
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY | 1988年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：P49 / P49
页数：1
相关论文
共 50 条
  • [41] Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
    Anna-Chiara Schaub
    Else Schneider
    Jorge F. Vazquez-Castellanos
    Nina Schweinfurth
    Cedric Kettelhack
    Jessica P. K. Doll
    Gulnara Yamanbaeva
    Laura Mählmann
    Serge Brand
    Christoph Beglinger
    Stefan Borgwardt
    Jeroen Raes
    André Schmidt
    Undine E. Lang
    Translational Psychiatry, 12
  • [42] Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
    Schaub, Anna-Chiara
    Schneider, Else
    Vazquez-Castellanos, Jorge F.
    Schweinfurth, Nina
    Kettelhack, Cedric
    Doll, Jessica P. K.
    Yamanbaeva, Gulnara
    Maehlmann, Laura
    Brand, Serge
    Beglinger, Christoph
    Borgwardt, Stefan
    Raes, Jeroen
    Schmidt, Andre
    Lang, Undine E.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [43] COMPARATIVE TRIAL OF KETANSERIN OR BENDROFLUAZIDE AS ADD-ON THERAPY IN HYPERTENSIVE PATIENTS UNCONTROLLED ON A BETA-BLOCKER ALONE
    KORLIPARA, K
    GOULD, SE
    TAYLOR, NA
    CHANDLER, TC
    DRUGS, 1988, 36 : 130 - 134
  • [44] Effect of add-on ramelteon therapy on sleep and circadian rhythm disruption in patients with schizophrenia: A randomized controlled trial
    Mishra, Archana
    Maiti, Rituparna
    Mishra, Biswa Ranjan
    Jena, Monalisa
    Nath, Santanu
    Sahu, Pallabi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : 109 - 118
  • [45] ADD-ON ADEFOVIR IS SUPERIOR TO A SWITCH TO ENTECAVIR AS RESCUE THERAPY FOR LAMIVUDINE-RESISTANT PATIENTS WITH CHRONIC HEPATITIS B
    Kim, Won
    Jung, Yong Jin
    Kim, Donghee
    HEPATOLOGY, 2010, 52 (04) : 540A - 540A
  • [46] Short-term Results of The Add-on Lacosamide Therapy in Patients with Drug-resistant Focal Onset Seizures
    Eren, Fulya
    Dirican, Ayten Ceyhan
    Gul, Gunay
    Tekin, Betul
    Atakli, Dilek
    Baybas, Sevim
    EPILEPSI, 2021, 27 (01): : 47 - 51
  • [47] LONG-TERM EFFICACY AND TOLERABILITY DATA ON TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH TREATMENT-RESISTANT EPILEPSY
    Papacostas, S.
    Dietis, A.
    Flourentzou, A.
    Stylianidou, G.
    Koukkoullis, R.
    Kkolou, E.
    EPILEPSIA, 2009, 50 : 194 - 195
  • [48] THREE-YEAR DATA ON EFFICACY AND TOLERABILITY OF LEVETIRACETAM AS ADD-ON THERAPY IN PATIENTS WITH TREATMENT-RESISTANT EPILEPSY
    Kkolou, E.
    Dietis, A.
    Flourentzou, A.
    Malikkidou, A.
    Petsa, M.
    Stylianidou, G.
    Papacostas, S.
    EPILEPSIA, 2009, 50 : 97 - 98
  • [49] UPDATE OF VALGANCICLOVIR ADD-ON THERAPY IN GLIOBLASTOMA. EFFECT IN NEW LY DIAGNOSED AND IN RECURRENT PATIENTS
    Stragliotto, G.
    Rahbar, A.
    Soderberg-Naucler, C.
    NEURO-ONCOLOGY, 2016, 18 : 59 - 59
  • [50] Effect of ranolazine as add-on therapy in type 2 diabetic dyslipidaemia patients: A randomised open-label trial
    Ravula, Sahithya Ravali
    Karunanidhi Santhana, Lakshmi
    Thangavel Mahalingam, Vijayakumar
    Janardanan Subramonia, Kumar
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
12345